🇺🇸 FDA
Pipeline program

cRGD-ZW800-1

NL71347.078.20

Phase 2 small_molecule active

Quick answer

cRGD-ZW800-1 for Oral cancer is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Oral cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials